Evotec and IMP will apply disease models to identify targets that Boehringer will chose from and further validate. Evotec, Boehringer Ingelheim, and the Research Institute of Molecular Pathology in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback